≡

Multiplex Assay Kit for Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay)

HBGF4; HST; HSTF1; KFGF; K-FGF; Heparin Secretory Transforming Protein 1; Kaposi Sarcoma Oncogene; Transforming Protein KS3; FGF-Related Oncogene

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 91-105 95
EDTA plasma(n=5) 90-102 97
heparin plasma(n=5) 81-89 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 90-101% 92-105% 91-105% 98-105%
EDTA plasma(n=5) 94-102% 84-95% 95-103% 90-99%
heparin plasma(n=5) 92-101% 90-101% 88-103% 84-93%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:FGF4) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Molecular Neurobiology Fibroblast Growth Factor 4 Is Required but not Sufficient for the Astrocyte Dedifferentiation Springer: Source
Oncotarget Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer pubmed:28445992
ANTICANCER RESEARCH Functional Characterization of VEGF- and FGF-induced Tumor Blood Vessel Models in Human Cancer Xenografts pubmed:29187438
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPA034Ra01 Recombinant Fibroblast Growth Factor 4 (FGF4) Positive Control; Immunogen; SDS-PAGE; WB.
PAA034Ra01 Polyclonal Antibody to Fibroblast Growth Factor 4 (FGF4) WB; IHC; ICC; IP.
MAA034Ra21 Monoclonal Antibody to Fibroblast Growth Factor 4 (FGF4) WB; IHC; ICC; IP.
SEA034Ra ELISA Kit for Fibroblast Growth Factor 4 (FGF4) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA034Ra CLIA Kit for Fibroblast Growth Factor 4 (FGF4) Chemiluminescent immunoassay for Antigen Detection.
LMA034Ra Multiplex Assay Kit for Fibroblast Growth Factor 4 (FGF4) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.